These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7689227)

  • 41. Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography.
    Serrière J; Dugua JM; Bossus M; Verrier B; Haser R; Gouet P; Guillon C
    J Mol Biol; 2011 Jan; 405(1):33-42. PubMed ID: 21035463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.
    Nicoli F; Chachage M; Clowes P; Bauer A; Kowour D; Ensoli B; Cafaro A; Maboko L; Hoelscher M; Gavioli R; Saathoff E; Geldmacher C
    BMC Infect Dis; 2016 Jul; 16():344. PubMed ID: 27450538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Full-length HIV-1 Tat protein necessary for a vaccine.
    Opi S; Péloponèse JM; Esquieu D; Watkins J; Campbell G; De Mareuil J; Jeang KT; Yirrell DL; Kaleebu P; Loret EP
    Vaccine; 2004 Aug; 22(23-24):3105-11. PubMed ID: 15297062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1.
    Brake DA; Goudsmit J; Krone WJ; Schammel P; Appleby N; Meloen RH; Debouck C
    J Virol; 1990 Feb; 64(2):962-5. PubMed ID: 1688630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-1 Tat protein as a potential AIDS vaccine.
    Goldstein G
    Nat Med; 1996 Sep; 2(9):960-4. PubMed ID: 8782444
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
    Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
    Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evidence for CTL-mediated selection of Tat and Rev mutants after the onset of the asymptomatic period during HIV type 1 infection.
    Guillon C; Stankovic K; Ataman-Onal Y; Biron F; Verrier B
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1283-92. PubMed ID: 17209772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.
    Marasco WA; LaVecchio J; Winkler A
    J Immunol Methods; 1999 Dec; 231(1-2):223-38. PubMed ID: 10648940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
    Zagury JF; Sill A; Blattner W; Lachgar A; Le Buanec H; Richardson M; Rappaport J; Hendel H; Bizzini B; Gringeri A; Carcagno M; Criscuolo M; Burny A; Gallo RC; Zagury D
    J Hum Virol; 1998; 1(4):282-92. PubMed ID: 10195253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins.
    Rolland M; Jensen MA; Nickle DC; Yan J; Learn GH; Heath L; Weiner D; Mullins JI
    J Virol; 2007 Aug; 81(16):8507-14. PubMed ID: 17537854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A universal anti-HIV-1 Tat epitope vaccine that is fully synthetic and self-adjuvanting.
    Goldstein G; Chicca JJ
    Vaccine; 2010 Jan; 28(4):1008-14. PubMed ID: 19931501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A monoclonal antibody defines a novel HIV type 1 Tat domain involved in trans-cellular trans-activation.
    Valvatne H; Szilvay AM; Helland DE
    AIDS Res Hum Retroviruses; 1996 May; 12(7):611-9. PubMed ID: 8743086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.
    Rossi P; Moschese V; Broliden PA; Fundaró C; Quinti I; Plebani A; Giaquinto C; Tovo PA; Ljunggren K; Rosen J
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8055-8. PubMed ID: 2479014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals.
    Calarota S; Jansson M; Levi M; Broliden K; Libonatti O; Wigzell H; Wahren B
    AIDS Res Hum Retroviruses; 1996 May; 12(8):705-13. PubMed ID: 8744581
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals.
    Addo MM; Altfeld M; Rosenberg ES; Eldridge RL; Philips MN; Habeeb K; Khatri A; Brander C; Robbins GK; Mazzara GP; Goulder PJ; Walker BD;
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1781-6. PubMed ID: 11172028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zn2+ binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis.
    Misumi S; Takamune N; Ohtsubo Y; Waniguchi K; Shoji S
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):297-304. PubMed ID: 15117453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intercellular traffic of human immunodeficiency virus type 1 transactivator protein defined by monoclonal antibodies.
    Demirhan I; Chandra A; Hasselmayer O; Chandra P
    FEBS Lett; 1999 Feb; 445(1):53-6. PubMed ID: 10069373
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.
    van Baalen CA; Pontesilli O; Huisman RC; Geretti AM; Klein MR; de Wolf F; Miedema F; Gruters RA; Osterhaus AD
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1913-8. PubMed ID: 9266987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.